Is urinary indolyl-3-acryloylglycine a biomarker for autism with gastrointestinal symptoms?
Date
2009
Authors
Wang, L.
Angley, M.T.
Gerber, J.P.
Young, R.L.
Abarno, D.V.
McKinnon, R.A.
Sorich, M.J.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Biomarkers, 2009; 14(8):596-603
Statement of Responsibility
Conference Name
Abstract
An autism spectrum disorder (ASD) diagnosis is based on clinical behaviours as there are no validated biological diagnostic tools. Indolyl-3-acryloylglycine (IAG) is a chemical produced by gut microflora and there are conflicting reports as to whether urinary levels are elevated in children with ASD compared with controls. Urinary IAG levels in morning urine samples were statistically significantly higher in children with ASD whose caregivers reported the presence of chronic gastrointestinal (GI) disturbance than children with ASD without chronic GI disturbance. Urinary IAG, however, was not statistically significantly higher in children with ASD, compared with siblings or unrelated controls without ASD.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2009 Informa UK